Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators.
Nayır Büyükşahin H, Emiralioğlu N, Yalçın E, Şen V, Selimoğlu Şen H, Arslan H, Başkan AK, Çakır FB, Koray CF, Yılmaz Aİ, Ercan F, Altıntaş DU, Serbes M, Keskin Ö, Arık E, Gülen F, Barlık M, Karcıoğlu O, Damadoğlu E, Köse M, Ersoy A, Bingöl A, Başaran E, Çakır EP, Aslan AT, Canıtez Y, Korkmaz M, Özdemir A, Harmancı K, Soydaş ŞS, Hangül M, Yüksel H, Özcan G, Korkmaz P, Kılıç M, Gayretli Aydın ZG, Çaltepe G, Can D, Doğru S, Kartal Öztürk G, Süleyman A, Topal E, Özsezen B, Hızal M, Demirdöğen E, Ogun H, Börekçi Ş, Yazan H, Çakır E, Şişmanlar Eyüboğlu T, Çobanoğlu N, Cinel G, Pekcan S, Özçelik U, Doğru D. Nayır Büyükşahin H, et al. Among authors: emiralioglu n. Pediatr Pulmonol. 2024 May 21. doi: 10.1002/ppul.27051. Online ahead of print. Pediatr Pulmonol. 2024. PMID: 38771207
Impact of interruption of CFTR modulator therapies.
Capraz Yavuz B, Yalcin E, Nayir Buyuksahin H, Sunman B, Guzelkas I, Alboga D, Akgul Erdal M, Demir HI, Atan R, Emiralioglu N, Dogru D, Ozcelik U, Kiper N. Capraz Yavuz B, et al. Among authors: emiralioglu n. J Cyst Fibros. 2024 May 18:S1569-1993(24)00069-9. doi: 10.1016/j.jcf.2024.05.006. Online ahead of print. J Cyst Fibros. 2024. PMID: 38762388
Correction to: Galectin-3 levels in children with cystic fibrosis.
Tural DA, Emiralioglu N, Akin S, Alboga D, Ozsezen B, Buyuksahin HN, Guzelkas I, Kasikci M, Sunman B, Gungor I, Yalcin E, Dogru D, Kiper N, Demirel AH, Ozcelik U. Tural DA, et al. Among authors: emiralioglu n. Eur J Pediatr. 2024 May 18. doi: 10.1007/s00431-024-05585-5. Online ahead of print. Eur J Pediatr. 2024. PMID: 38761224 No abstract available.
Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international study.
Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Calmes D, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem Eralp E, van Gogh C, Gokdemir Y, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kieninger E, Kim S, Lorent N, Ozcelik U, Pioch C, Raidt J, Reula A, Roehmel J, Sperstad Kennelly S, Yiallouros P; EPIC-PCD team; Goutaki M. Lam YT, et al. Among authors: emiralioglu n. ERJ Open Res. 2024 Mar 4;10(2):00932-2023. doi: 10.1183/23120541.00932-2023. eCollection 2024 Mar. ERJ Open Res. 2024. PMID: 38444659 Free PMC article.
Galectin-3 levels in children with cystic fibrosis.
Ademhan Tural D, Emiralioglu N, Akin S, Alboga D, Ozsezen B, Nayir Buyuksahin H, Guzelkas I, Kasikci M, Sunman B, Gungor I, Yalcin E, Dogru D, Kiper N, Demirel AH, Ozcelik U. Ademhan Tural D, et al. Among authors: emiralioglu n. Eur J Pediatr. 2024 May;183(5):2333-2342. doi: 10.1007/s00431-024-05479-6. Epub 2024 Mar 2. Eur J Pediatr. 2024. PMID: 38430280
Successful atorvastatin treatment of pulmonary alveolar proteinosis in a child with GM-CSF receptor deficiency.
Nayır Büyükşahin H, Yalçın E, Özdemir A, Haliloglu M, Orhan D, Griese M, Gothe F, Rapp C, Hardenberg SGV, Debbağ S, Güzelkaş İ, Emiralioğlu N, Doğru D, Özçelik U, Kiper N. Nayır Büyükşahin H, et al. Among authors: emiralioglu n. Pediatr Pulmonol. 2024 Jun;59(6):1777-1780. doi: 10.1002/ppul.26946. Epub 2024 Feb 27. Pediatr Pulmonol. 2024. PMID: 38411295 No abstract available.
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia.
Kos R, Goutaki M, Kobbernagel HE, Rubbo B, Shoemark A, Aliberti S, Altenburg J, Anagnostopoulou P, Athanazio RA, Beydon N, Dell SD, Emiralioglu N, Ferkol TW, Loebinger MR, Lorent N, Maître B, Marthin J, Morgan LC, Nielsen KG, Ringshausen FC, Shteinberg M, Tiddens HAWM, Maitland-Van der Zee AH, Chalmers JD, Lucas JSA, Haarman EG. Kos R, et al. Among authors: emiralioglu n. ERJ Open Res. 2024 Jan 8;10(1):00115-2023. doi: 10.1183/23120541.00115-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38196895 Free PMC article.
The airway microbiota in siblings with primary ciliary dyskinesia: Related factors and correlation with clinical characteristics.
Ademhan Tural D, Kasikci M, Eryilmaz Polat S, Ozsezen B, Hizal M, Sunman B, Nayir Büyüksahin H, Guzelkas I, Altay O, Dolgun TY, Emiralioglu N, Yalcin E, Dogru D, Kiper N, Hascelik G, Diker KS, Ozcelik U. Ademhan Tural D, et al. Among authors: emiralioglu n. Pediatr Pulmonol. 2024 Mar;59(3):695-706. doi: 10.1002/ppul.26816. Epub 2023 Dec 13. Pediatr Pulmonol. 2024. PMID: 38088243
Lack of Correlation of Sinonasal and Otologic Reported Symptoms With Objective Measurements Among Patients With Primary Ciliary Dyskinesia: An International Study.
Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Caversaccio N, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem E, Gogh CV, Gokdemir Y, Gunaydın O, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kim S, Lorent N, Ozcelik U, Pioch C, Poirrier AM, Reula A, Roehmel J, Yiallouros P, Goutaki M. Lam YT, et al. Among authors: emiralioglu n. Clin Exp Otorhinolaryngol. 2023 Nov;16(4):407-412. doi: 10.21053/ceo.2023.01130. Epub 2023 Nov 17. Clin Exp Otorhinolaryngol. 2023. PMID: 38056830 Free PMC article. No abstract available.
123 results